MedAdvisor Limited (ASX: MDR)
Australia
· Delayed Price · Currency is AUD
0.300
+0.010 (3.45%)
Nov 21, 2024, 4:10 PM AEST
MedAdvisor Revenue
In the fiscal year ending June 30, 2024, MedAdvisor had annual revenue of 122.11M AUD with 24.64% growth. MedAdvisor had revenue of 46.56M in the half year ending June 30, 2024, with 60.00% growth.
Revenue
122.11M
Revenue Growth
+24.64%
P/S Ratio
1.35
Revenue / Employee
n/a
Employees
n/a
Market Cap
165.39M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 122.11M | 24.14M | 24.64% |
Jun 30, 2023 | 97.96M | 30.21M | 44.60% |
Jun 30, 2022 | 67.75M | 28.98M | 74.74% |
Jun 30, 2021 | 38.77M | 29.17M | 303.77% |
Jun 30, 2020 | 9.60M | 1.36M | 16.51% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 22.18B |
ResMed Inc. | 6.93B |
Pro Medicus Limited | 161.50M |
Fisher & Paykel Healthcare Corporation Limited | 1.60B |
Cochlear Limited | 2.24B |
Sonic Healthcare Limited | 8.97B |
Ramsay Health Care Limited | 16.66B |
Telix Pharmaceuticals Limited | 645.68M |